Genomics Account Manager (m/f/d) (jun./sen.)
Job Description
We are permanently looking for a Genomics Account Manager (m / f / d) in the DACH for research :
The successful candidate will be expected to grow the revenues across all genomic service areas in which we are present, including Next Generation Sequencing, Applied Genomics markets, Sanger sequencing, Oligos, Gene synthesis, Microarray, Genotyping.
The position is home-office based with frequent travel (70%) across the DACH region and to Eurofins Genomics production sites (mostly in Germany). .
You will be responsible for :
- Increasing sales in all genomic service areas in which we are represented, including Next Generation Sequencing, Applied Genomics Markets, Sanger Sequencing, Oligos, Gene Synthesis, Microarray and Genotyping
- Achieving sales targets in the relevant territory
- Developing the pipeline by discovering and mapping new projects and opportunities
- Carrying out regular reporting : Sales and competitive analysis. Intensive use of CRM
- Implementing the sales strategy in collaboration with the Country Manager and adapting it to the local situation
Qualifications
- You are based in Germany with an in-depth knowledge in sales of genomics technology within the research academic, biotech and industrial / commercial sectors
- Scientific / technical background, B.Sc. in science or higher
- You have 5 years of sales
- You have experience with genome applications (current and emerging) and associated analysis methods
- Strong knowledge of commercial processes and CRM, sales forecasting, sales and market analysis, sales and marketing reports
- You are results driven : Think strategically, yet understand details
- You are self-motivated : Ability to work autonomously and deliver results against targets
- You are enthusiastic and passionate about sales, with the ability to communicate this enthusiasm to customers
- Numerate : Intelligent, numerate with business acumen, a quick thinker and eager to learn
- High integrity : Must work independently, and without daily supervision
Additional Information
We offer you :
- A varied working day in a dynamic group of companies
- 30 days annual leave and various special leave days
- Numerous social benefits, such as
- Company pension scheme
- Corporate benefits (discount codes for various providers)
- Benefits in kind (€50 per month)
- Health management (e.g. participation in health courses, regular eye examinations by our company doctor and much more)
- Wide range of further training opportunities
- Free coffee and tea & fresh fruit
Eurofins Scientific is an international life sciences company, providing a unique range of analytical testing services to clients across multiple industries, to make life and our environment safer, healthier and more sustainable.
From the food you eat, to the water you drink, to the medicines you rely on, Eurofins works with the biggest companies in the world to ensure the products they supply are safe, their ingredients are authentic and labelling is accurate.
Eurofins believes it is a global leader in food, environmental, pharmaceutical and cosmetics products testing and in agroscience CRO services.
It is also one of the global independent market leaders in certain testing and laboratory services for genomics, discovery pharmacology, forensics, CDMO, advanced material sciences and in the support of clinical studies.
In over just 30 years, Eurofins has grown from one laboratory in Nantes, France to over 62,000 staff across a network of more than over 1000 independent companies in over 62 countries and operating more than 900 laboratories.
Eurofins offers a portfolio of over 200,000 analytical methods to evaluate the safety, identity, composition, authenticity, origin, traceability and purity of biological substances and products, as well as providing innovative clinical diagnostic testing services, as one of the leading global emerging players in specialised clinical diagnostics testing.
In 2023, Eurofins generated total revenues of EUR € 6.515 billion, and has been among the best performing stocks in Europe over the past 20 years.